BPG is committed to discovery and dissemination of knowledge
Minireviews
Copyright: ©Author(s) 2026.
World J Hepatol. May 27, 2026; 18(5): 117184
Published online May 27, 2026. doi: 10.4254/wjh.v18.i5.117184
Figure 2
Figure 2 The potential pathophysiological mechanisms of congenital portal hypertension essentially involve abnormalities in the structure or hemodynamics of the portal venous system. Including: Congenital venous developmental defects, congenital hepatic fibrosis, perinatal venous thrombosis, molecular genetic factors such as gene mutations, and environmental factors such as perinatal infections and drug exposure. Additionally, complications arising in related sites due to congenital portal hypertension may occur. FBN1: Fibrillin 1; NOTCH1: Notch receptor 1; ACVRL1: Activin A receptor like type 1; MRI: Magnetic resonance imaging.


Write to the Help Desk